Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01076114 · ClinicalTrials.gov registry record

Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early Glaucoma

A clinical trial, sponsored by Northwell Health.

Completed
Registry status
58
Enrollment target

NCT01076114 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 58 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01076114 has completed, sponsored by Northwell Health.

COMPLETED
Registry status
58 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate if critical flicker fusion is a more reliable method for detection of early glaucoma compared to automated visual fields in comparison to subjects without evidence of glaucoma or optic nerve disease.

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2010-02
Est. Completion 2011-02

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT01076114

The ClinicalTrials.gov registry entry for NCT01076114 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01076114 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01076114 about?

NCT01076114 is a clinical study titled "Comparison of Critical Flicker Fusion Versus Automated Visual Fields in the Detection of Early Glaucoma". The purpose of this study is to evaluate if critical flicker fusion is a more reliable method for detection of early glaucoma compared to automated visual fields in comparison to subjects without evidence of glaucoma or optic nerve disease.

What is the current status of trial NCT01076114?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2010-02. Estimated completion is 2011-02.

Who is sponsoring clinical trial NCT01076114?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.